1. "Clifford Hudis"
  2. "Andrew Seidman"
Formats
  1. Meeting Abstract (55)
  2. Journal Article (54)
  3. Conference Paper (7)
Groups
  1. Breast Medicine Service (116)
  2. Department of Medicine (116)
  3. Solid Tumor Oncology Division (116)
  4. Survivorship Research (116)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (85)
  6. Epidemiology and Biostatistics (41)

More Groups

People
  1. Andrew Seidman (116)
  2. Clifford Hudis (116)
  3. Larry Norton (85)
  4. Teresa Gilewski (38)
  5. Gabriella D'Andrea-Carlino (32)
  6. Violante Currie (32)

More People

Years
  1. 2018 (2)
  2. 2016 (1)
  3. 2014 (2)
  4. 2013 (5)
  5. 2012 (8)
  6. 2011 (5)

More Years

Publications
  1. Journal of Clinical Oncology (41)
  2. Breast Cancer Research and Treatment (17)
  3. Cancer Research (10)
  4. Clinical Breast Cancer (8)
  5. Clinical Cancer Research (7)
  6. Seminars in Oncology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (41)
  2. American Association for Cancer Research (19)
  3. Springer (18)
  4. Elsevier Inc. (17)
  5. Informa Healthcare (5)
  6. Oxford University Press (5)

More Publishers

Results (116)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characteristics and prognostic factors for patients with HER2-overexpressing breast cancer and brain metastases in the era of HER2-targeted therapy: An argument for earlier detection
    Journal Article

    Morikawa, A.; Wang, R.; Patil, S.; Diab, A.; Yang, J.; Hudis, C. A.; McArthur, H. L.; Beal, K.; Seidman, A. D.
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel and dasatinib in metastatic breast cancer
    Journal Article

    Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
    Clinical Breast Cancer (2018)

    Fulltext@MSK | Save
  • Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage breast cancer
    Meeting Abstract

    Cadoo, K.; Kaufman, P. A.; Hudis, C.; Chang, C.; Berrak, E.; Song, J.; Seidman, A. D.; Traina, T. A.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase 2 feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate with or without prophylactic growth factor (GF) for adjuvant treatment of early-stage breast cancer (EBC)
    Meeting Abstract

    Traina, T. A.; Kaufman, P. A.; Cadoo, K. A.; Hudis, C. A.; Chang, C.; Berrak, E.; Song, J.; Cox, D.; Seidman, A. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Patient characteristics and outcomes for patients with HER2-overexpressing breast cancer with brain metastases undergoing radiation therapy in the pre- and post adjuvant trastuzumab era
    Meeting Abstract

    Morikawa, A.; Diab, A.; Patil, S.; Yang, T. J.; Hudis, C. A.; McArthur, H. L.; Beal, K.; Seidman, A. D.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Radiation therapy for breast cancer (BC) with central nervous system (CNS) metastases: A contemporary experience at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Morikawa, A.; Diab, A.; Patil, S.; Forte, V.; Blum, B.; Young, R. J.; Beal, K.; Hudis, C.; Seidman, A. D.; Mcarthur, H. L.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer
    Journal Article

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Moynahan, M. E.; Lake, D.; Forero, A.; Wright, G. S.; Hackney, M. H.; Clawson, A.; Norton, L.; more...
    Clinical Breast Cancer (2013)

    Fulltext@MSK | Save
  • Electrophysiological features of taxane-induced polyneuropathy in patients with breast cancer
    Journal Article

    Chen, X.; Stubblefield, M. D.; Custodio, C. M.; Hudis, C. A.; Seidman, A. D.; De Angelis, L. M.
    Journal of Clinical Neurophysiology (2013)

    Fulltext@MSK | Save